FDA Eli Lilly - Search News

Eli Lilly, Obesity Drug

Hosted on MSN · 2h

Eli Lilly says it will spend billions to move drug manufacturing to U.S. soil

Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, part of a doubling of its investment in manufacturing.

UPI on MSN · 7h

Ely Lilly to spend billions on new pharmaceutical manufacturing sites

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in pharmaceutical production.

InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing measles outbreak in Texas,

Off-brand weight loss drug makers are suing the FDA

CNN on MSN · 5d

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Drug compounders sue FDA over declaration ending Wegovy shortage

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” but in earnings Monday still forecast higher revenue and profits in 2025.

Quartz on MSN · 1d

Off-brand weight loss drug makers are suing the FDA again

A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another lawsuit against the U.S. Food and Drug Administration (FDA). This time, it’s over the health regulator’s decision to remove semaglutide — the active ingredient in Novo Nordisk’s (NVO) popular Ozempic and Wegovy treatments — from its drug shortage list.

5don MSN

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

5h

Lilly to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.

FierceBiotech17h

Eli Lilly buys Organovo's FXR program for $10M, sending biotech's stock skyrocketing 244%

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...

1don MSN

Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...

1don MSN

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...

Lilly plans major expansion manufacturing capabilities in the U.S.

Eli Lilly announces plans to build four new U.S. manufacturing facilities, enhancing domestic pharmaceutical production and creating jobs.

Lilly banks stockpile of oral GLP-1 drug with potential launch still more than a year away

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

AFP on MSN9h

Eyeing Trump trade policy shakeup, Eli Lilly to build 4 US factories

US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results